Form 4: Red Violet Director Lisa Stanton Buys 1,000 Shares of Common Stock
SEC Form 4 Filing
Lisa Stanton, a director at Red Violet, Inc., purchased 1,000 shares of the company's common stock at a price of $36.12 per share on March 7, 2025.
Summary
- On March 7, 2025, Lisa Stanton, a director of Red Violet, Inc., acquired 1,000 shares of common stock at $36.12 per share.
- Following the transaction, Stanton directly owns 26,815 shares of Red Violet's common stock.
- The reported holdings include restricted stock units (RSUs) that are convertible into common stock on a one-for-one basis, vesting at various dates in the future.
- These RSUs were granted on multiple dates, including October 12, 2022, November 30, 2023, April 23, 2024, November 4, 2024 and March 4, 2025, with vesting schedules extending through November 1, 2027, subject to accelerated vesting under certain conditions.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. A director purchasing shares is generally a good sign, but the small quantity suggests it's not a major event.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's view of the company's prospects.
Comparison to Industry Standards
- Director stock purchases are common across publicly traded companies and are generally viewed positively by the market.
- The size of the purchase (1,000 shares) is relatively small, suggesting it's more of a symbolic gesture of confidence rather than a major investment shift.
- Comparable companies in the technology and data analytics space also see insider transactions, with the significance varying based on the size and frequency of the trades.
Stakeholder Impact
- The stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 10/12/2022 | Date of original grant for 1,666 RSUs, vesting on November 1, 2025. |
| 11/30/2023 | Date of original grant for 3,333 RSUs, vesting in two equal installments on December 1, 2025, and December 1, 2026. |
| 04/23/2024 | Date of original grant for 2,666 RSUs, vesting in two equal installments on December 1, 2025, and 2026. |
| 11/04/2024 | Date of original grant for 6,720 RSUs, vesting in approximately three equal installments on November 1, 2025, November 1, 2026, and November 1, 2027. |
| 03/04/2025 | Date of original grant for 860 RSUs, vesting 216 shares on November 1, 2025 and 322 shares on each of November 1, 2026 and 2027. |
| 03/07/2025 | Date of transaction: Lisa Stanton purchased 1,000 shares of RDVT common stock. |
| 03/10/2025 | Date of Form 4 filing. |
| 11/01/2025 | Vesting date for some of the RSUs. |
| 12/01/2025 | Vesting date for some of the RSUs. |
| 11/01/2026 | Vesting date for some of the RSUs. |
| 12/01/2026 | Vesting date for some of the RSUs. |
| 11/01/2027 | Vesting date for some of the RSUs. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.